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Abstract
OBJECTIVE: To identify prognostic factors in mid-
dle-aged and elderly patients with community-ac-
quired pneumonia (CAP) who underwent integrat-
ed interventions involving traditional Chinese med-
icine (TCM) and modern medicine.
METHODS: Patients aged ≥45 years and diagnosed
with CAP were divided into a middle-aged cohort
(45-59 years) and an elderly cohort (≥60 years), and
clinical data comprising 75 predictor variables in
seven classes were collected. After replacing miss-
ing data, calibrating multicenter differences and
classifYing quantitative data, univariate and multi-
variate analysis were performed.
RESULTS: On multivariate analysis, eight indepen-
dent risk factors – respiration rate, C reactive pro-
tein (CRP), cost of hospitalization, anemia, gasping,
confusion, moist rales and pneumonia severity in-
dex (PSI)– were correlated with the outcome "not
cured" in the elderly cohort. Nine factors– neutro-
phil percentage (Neu% ), blood urea nitrogen
(BUN), time to clinical stability, appetite, anemia,
confusion, being retired or unemployed, Gram-neg-
ative bacterial infection and educational level –
were correlated with not cured in the middle-aged
cohort.
CONCLUSION: Independent predictive risk factors
correlated with adverse outcomes in elderly pa-
tients were higher respiration rate, CRP≥four times
the mean or median for the patient's center, cost of
hospitalization>11,323 RMB and PSI>II, plus ane-
mia, gasping, confusion and moist rales; those in
middle-aged patients were higher Neu% , BUN≥
mean or median, loss of appetite, anemia, confu-
sion, being retired or unemployed and lower edu-
cational level. Gram-negative bacterial infection
and time to clinical stability>9 days were protective
factors.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Community-acquired pneumonia (CAP) has high mor-
bidity and mortality in adults and the elderly [1-3]. To
improve these adverse outcomes, many studies had
been performed to identify prognostic factors. Various
outcomes have been used, however, including
short-term mortality [3-13], long-term mortality[14], treat-
ment failure[15-17] and other end points [18-23], and only a
few studies have explored the differences between dif-
ferent age groups[4]. In addition, most of these prognos-
tic factors were identified using data from patients who
received modern medical treatments. Thus, the conclu-
sions of these previous studies are of limited relevance
in worldwide clinical practice. Research involving a
greater number of common outcomes, comparison be-
tween different age groups and complex interventions
are needed. Compared with research on end points
such as mortality and treatment failure, studies focused
on "not-cured" as an outcome may benefit more pa-
tients with CAP. In addition, people in different age
groups differ physiologically and psychologically, and
risk factors may vary between the young, middle-aged
and elderly. Furthermore, traditional Chinese medicine
(TCM) is thought to have advantages in improving
quality of life and reducing hospitalization time and ad-
verse effects[24]. The objective of this study was to identi-
fy prognostic factors in middle-aged and elderly pa-
tients with CAP who underwent integrated treatment
involving TCM and modern medicine.
METHODS
Setting
Medical data were obtained from a multicenter clinical
observation supported by a national project, A Theoret-
ical Study on Curative Effect Evaluation Methods
Based on Traditional Chinese Medical Diagnosis and
Treatment for Pneumonia. Data were collected from
the First Affiliated Hospital of Changchun University
of Chinese Medicine (Changchun, China), the First Af-
filiated Hospital of Henan College of Traditional Chi-
nese Medicine (Zhengzhou, China), the Jiangsu Prov-
ince Hospital of Traditional Chinese Medicine (Nan-
jing, China) and the Affiliated Hospital of Shandong
University of Chinese Medicine (Jinan, China) from
December 17, 2006 to December 22, 2008. The study
was approved by the local ethics committees.
Inclusion criteria
Patients were eligible for entry into this study if they:
1) were older than 45 years; 2) had been diagnosed
with CAP; 3) had been diagnosed with the syndrome
of wind-heat in the lung, the syndrome of exopathic
cold and interior heat, the syndrome of accumulation
of phlegm-heat in the lung, the syndrome of accumula-
tion of phlegm-dampness in the lung, the syndrome of
insufficiency of the lung and the spleen Qi, or the syn-
drome of deficiency of both Qi and Yin; and 4) had
signed an informed consent form.
Exclusion criteria
Patients were excluded if they: 1) had bronchiectasis,
lung abscess, postobstructive pneumonia, radiation
pneumonia, HIV infection, active tuberculosis or cys-
tic pulmonary fibrosis; 2) were taking immunosuppres-
sive agents after organ or bone marrow transplantation;
3) had received chemotherapy or radiotherapy during
the past 90 days; 4) had been hospitalized in the past
30 days; or 5) had been diagnosed with the syndrome
of heat attack of the pericardium or the syndrome of
exhaustion of vital-Qi resulting from invasion of patho-
gens.
Groups
After patient selection, the eligible participations were
divided into two groups based on age: middle-aged
(45-59 years) and elderly (≥60 years). The groups un-
derwent the same interventions and outcome assess-
ments, but were analyzed by cohort.
Outcome, predictor variables and quality control
The only outcome was "not cured of CAP" by the
14th day of hospitalization or the time of discharge [25].
Data on 75 predictor variables in seven classes (demo-
graphics, original disease and previous conditions, com-
plications, symptoms and signs, auxiliary examination
results, severity and other factors) were collected.
Among these variables, smoking refers to the total
number of cigarettes that the patient had smoked in
the past, daily alcohol consumption refers to grams of
absolute ethanol consumed per day, hospitalization fre-
quency refers to the number of hospitalizations due to
CAP in the past year, and cost of hospitalization refers
to, for example, the costs of medicines, laboratory
tests, examinations, treatments, bed and nursing. Crite-
ria for clinical stability[1] were: CURB65 (confusion +
blood urea nitrogen (BUN) >19 mg/dL + respiratory
rate≥30 breaths/min+systolic blood pressure (SBP)<90
mmHg or diastolic blood pressure (DBP)≤60 mmHg+
age≥65 years)[6]; Charlson Comorbidity Index (CCI)[26];
and pneumonia severity index (PSI)[27].
The data were collected on the first day of the study,
which was the day when the patients' hospitalization
began and was defined as lasting from the moment
that the patient arrived at the inpatient department of
respiratory medicine until midnight that day. Subse-
quent days were the subsequent midnight–midnight
24-h periods. When more than one measurement of
the same physiological variable was recorded within a
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24-hour period, only the first record was included in
the analysis.
Strict quality control was performed in every center in-
volved in the data collection procedure. First, educa-
tion on the background of the study, implementation
protocols and standard operating procedures were pro-
vided to the clinical investigators. Second, data were
collected in each center simultaneously and case report
forms (CRFs) were completed within required time pe-
riods. The CRFs were reviewed and modified by the
co-primary investigators in each center, then submitted
to the First Affiliated Hospital of Henan College of Tra-
ditional Chinese Medicine for further data analysis.
Diagnostic criteria and treatment
Modern medical diagnostic criteria and treatments
were based on the Diagnosis and Treatment Guideline
of CAPby the Chinese Society of Respiratory Dis-
eases[28]; those for TCM were based on the Diagnosis
and Treatment Guideline of CAP with Traditional Chi-
nese Medicine by the research group for the project A
Theoretical Study on Curative Effect Evaluation Meth-
ods Based on Traditional Chinese Medical Diagnosis
and Treatment for Pneumonia.
Statistical analysis
According to the principle[29] that difference calibration
should be conducted for laboratory data obtained from
different centers, and because quantitative data needed
to be analyzed as qualitative data, two data transforma-
tion steps were performed. In step 1, the primary data
for each patient, minus the mean or median value of
the laboratory findings provided by the patient's cen-
ter, were divided by the difference between the highest
and lowest values of each variable to obtain standard-
ized data for analysis[30]. In step 2, the data were classi-
fied into three groups: A, the original data; B, data that
had been transformed into dichotomous variables
(greater than or less than a cut-off point determined by
the maximal Youden's index using the receiver operat-
ing characteristic (ROC) curve); and C, data that had
been transformed to multivariate variables using a sim-
ple qualitative classification – laboratory quantitative
findings were divided into three groups, less or equal
to -0.5, between -0.5 and 0.5, or more than 0.5,
non-laboratory data with a normal range (e.g. tempera-
ture, pulse, respiration rate) were divided according to
"less than minimal value, normal range or greater than
maximal value", and other data, such as age and smok-
ing, were divided by tradition and experience.
Five methods were used for analysis. First, the one-sam-
ple Kolmogorov–Smirnov test was performed to test
normality. To identify variables correlated with CAP,
univariate analysis using the two independent samples
t-test was performed on data with a normal distribu-
tion, the chi-square test with 2 × 2 contingency tables
was used for dichotomous variables, and a two indepen-
dent samples nonparametric test (Mann–Whitney U)
was conducted for data with a non-normal distribution
and for multivariate variables. For multivariate analy-
sis, logistic regression analysis was used. Variables with
statistically significant results at the P<0.05 level were
considered to be risk factors. Missing quantitative data
were replaced with the mean if the primary data were
normally distributed or with the median if the primary
data were not normally distributed. Missing qualitative
data were replaced with the mode of the non-missing
data for that variable.
RESULTS
Subject characteristics
Four hundred and thirteen patients met the inclusion
criteria on hospitalization. Of these, seven patients
who died were excluded from the analysis because their
families refused permission to use their data, two were
lost due to lack of contact information and four re-
fused to complete the investigation for unclear reasons.
Four hundred patients (age 67.48±11.535 years, 46%
female) were therefore enrolled in the outcome analy-
sis. Two hundred and ninety-three (age 73.11 ± 7.482
years, 43% female, 219 (74.7%) not cured) were in the
elderly cohort and 107 (age 52.07±4.414 years, 52%
female, 79 (73.8%) not cured) were in the middle-aged
cohort.
Classification
The cut-off points obtained from the ROC curves
were as follows: age, 69.5; smoking, 49,275; daily alco-
hol consumption, 53.493; body mass index (BMI),
24.384; hospitalization frequency, 0.5; temperature,
36.85; pulse, 82.5; respiration rate, 21.5; SBP, 139;
DBP, 77.5; WBC, 0.123; hemoglobin, – 0.23; lym-
phocyte percentage (Lym%), –0.304; neutrophil per-
centage (Neu%), 0.408; serum creatinine (Cr), 0.348;
BUN, 0.024; C-reactive protein (CRP), 2.891; albu-
min, 0.154; blood glucose, 0.011; serum sodium, –
0.246; time to clinical stability, 9; CURB65, 1.5; cost
of hospitalization, 11,323.245; and CCI, 3.5.
Quantitative data were divided into dichotomous vari-
ables (group B) according to whether they were greater
or less than the cut-off point. They were divided into
multivariate variables (group C) as follows: age (1=
45-59, 2=60-95); smoking (1=0, 2=1-105, 3=>105);
daily alcohol consumption (1=0, 2=1-49, 3=>50); BMI
(1=<18.5, 2=18.5-22.9, 3=≥23); hospitalization fre-
quency (1=0 or 1, 2=≥2); temperature (1=≤37.2, 2=
37.3-38, 3=38.1-41); pulse (1 £100, 2=>100); respira-
tion rate (1=12–20, 2=21-29, 3=≥30); SBP (1=<140,
2=140-159, 3=≥160); DBP (1=<60, 2=60-89, 3=≥90);
time to clinical stability (1=0-2, 2=3-7, 3=>7);
CURB65 (1=0-1, 2=2, 3=≥3); cost of hospitalization
(1=<5000, 2=5000-10,000, 3=>10,000); CCI (1=0-3,
2=4-6, 3=≥7); and laboratory findings (1=<-0.5,
2=-0.5-0.5, 3=>0.5).
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Univariate analysis
In the elderly cohort, 27 variables in group A were asso-
ciated with the not-cured outcome: age, hospitalization
frequency, pulse, respiration rate, BUN, CRP, time to
clinical stability, CURB65, cost of hospitalization,
CCI, use of glucocorticoid, use of anti-infective agents,
aspiration, respiratory failure, hypercapnia, hypoxemia,
anemia, gasping, loss of appetite, confusion, dull reac-
tion, cyanotic lips, moist rales, time to WBC reduced
to normal, time to temperature reduced to normal, se-
verity and PSI. Twenty-eight variables in group B asso-
ciated with the not-cured outcome comprised the 27
listed above plus SBP. Twenty-one variables in group C
comprised all of the variables listed for group A except
age, hospitalization frequency, pulse, BUN, CRP and
cost of hospitalization.
In the middle-aged cohort, 13 variables in group A
were associated with the not-cured outcome: hemoglo-
bin, albumin, blood glucose, time to clinical stability,
cost of hospitalization, anemia, loss of appetite, confu-
sion, dry rales, being retired or unemployed, Gram-neg-
ative bacterial infection, educational level less than
high school and severity. Seventeen variables in group
B associated with the not-cured outcome comprised
the 13 listed above plus Lym%, Neu%, BUN and se-
rum sodium. Eleven variables in group C comprised all
of the variables listed for group A except hemoglobin
and albumin.
Multivariate analysis
In the elderly cohort, five independent predictive fac-
tors in group A were correlated with the not-cured out-
come: respiration rate, anemia, confusion, moist rales
and PSI. Six independent predictive factors in group B
were: CRP, cost of hospitalization, anemia, confusion,
moist rales and PSI. Five independent predictive fac-
tors in group C were: anemia, gasping, confusion,
moist rales and PSI. Merging the three groups, we
found that eight independent predictive factors were
correlated with the not-cured outcome in the elderly
cohort: respiration rate, CRP, cost of hospitalization,
anemia, gasping, confusion, moist rales and PSI (Table
5-1, 5-2, 5-3).
Table 5-1 Prognosis factors of no cure outcome of CAP in elderly cohort with combined treatment of TCM and modern medicine
by multivariate analyses
Characters
A group
Respiration rate
Anemia
Confusion
Moist rales
PSI
B
0.119
1.375
1.074
0.931
0.522
S.E.
0.060
0.475
0.378
0.396
0.214
Wald
3.860
8.372
8.067
5.515
5.929
df
1
1
1
1
1
P values
0.049
0.004
0.005
0.019
0.015
Exp(B)
1.126
3.957
2.928
2.537
1.685
95.0% C.I.
Lower
1.000
1.559
1.395
1.167
1.107
Upper
1.268
10.046
6.147
5.519
2.564
Table 5-2 Prognosis factors of no cure outcome of CAP in elderly cohort with combined treatment of TCM and modern medicine
by multivariate analyses
Characters
B group
CRP
Cost of hospitalization
Anemia
Confusion
Moist rales
PSI
B
1.167
0.982
1.181
1.069
1.008
0.552
S.E.
0.370
0.485
0.482
0.383
0.393
0.216
Wald
9.976
4.096
6.009
7.794
6.586
6.525
df
1
1
1
1
1
1
P values
0.002
0.043
0.014
0.005
0.010
0.011
Exp(B)
3.213
2.669
3.256
2.913
2.740
1.738
95.0% C.I.
Lower
1.557
1.031
1.267
1.375
1.269
1.137
Upper
6.630
6.905
8.369
6.171
5.917
2.655
182
JTCM |www. journaltcm. com June 15, 2012 |volume 32 | Issue 2 |
Li JS et al. Prognosis factors of CAP in patients aged ≥ 45 yrs
Table 5-3 Prognosis factors of no cure outcome of CAP in elderly cohort with combined treatment of TCM and modern medicine
by multivariate analyses
Characters
C group
Anemia
Gasping
Confusion
Moist rales
PSI
B
1.395
0.675
1.119
0.914
0.569
S.E.
0.493
0.319
0.376
0.395
0.212
Wald
8.001
4.467
8.853
5.339
7.199
df
1
1
1
1
1
P values
0.005
0.035
0.003
0.021
0.007
Exp(B)
4.036
1.964
3.063
2.493
1.766
95.0% C.I.
Lower
1.535
1.050
1.465
1.149
1.166
Upper
10.613
3.674
6.402
5.413
2.676
Table 6-1 Prognosis factors of no cure outcome of CAP in middle aged cohort with combined treatment of TCM and modern
medicine by multivariate analyses
Characters
A group
Loss of appetite
Retired or unemployed
Gram-negative bacteria infection
≤high school education
B
1.661
2.068
-2.249
1.502
S.E.
0.636
0.962
0.655
0.606
Wald
6.815
4.620
11.778
6.132
df
1
1
1
1
P values
0.009
0.032
0.001
0.013
Exp(B)
5.263
7.908
0.106
4.490
95.0% C.I.
Lower
1.513
1.200
0.029
1.368
Upper
18.311
52.116
0.381
14.741
Table 6-2 Prognosis factors of no cure outcome of cap in middle aged cohort with combined treatment of tcm and modern medi-
cine by multivariate analyses.
Characters
B group
Neu%
BUN
Clinical stability time >9 days
Loss of appetite
Gram-negative bacteria
B
1.610
2.258
-1.975
1.476
-1.917
S.E.
0.724
0.755
0.958
0.671
0.691
Wald
4.945
8.956
4.250
4.840
7.701
df
1
1
1
1
1
P values
0.026
0.003
0.039
0.028
0.006
Exp(B)
5.003
9.567
0.139
4.377
0.147
95.0% C.I.
Lower
1.210
2.180
0.021
1.175
0.038
Upper
20.680
41.989
0.907
16.307
0.569
Table 6-3 Prognosis factors of no cure outcome of CAP in middle aged cohort with combined treatment of TCM and modern
medicine by multivariate analyses
Characters
C group
Anemia
Confusion
Retired or unemployed
Gram-negative bacteria
B
2.493
2.349
2.364
-2.185
S.E.
1.185
1.178
1.003
0.681
Wald
4.426
3.978
5.556
10.298
df
1
1
1
1
P values
0.035
0.046
0.018
0.001
Exp(B)
12.100
10.476
10.635
0.112
95.0% C.I.
Lower
1.186
1.041
1.489
0.030
Upper
123.475
105.381
75.943
0.427
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In the middle-aged cohort, four independent predic-
tive factors in group A were correlated with the
not-cured outcome: loss of appetite, occupation,
Gram-negative bacterial infection (positive factor) and
educational level less than high school. Five indepen-
dent predictive factors in group B were: Neu%, BUN,
time to clinical stability >9 days (positive factor), loss
of appetite and Gram-negative bacterial infection (posi-
tive factor). Four independent predictive factors in
group C were: anemia, confusion, being retired or un-
employed, and Gram-negative bacterial infection (posi-
tive factor). Merging these results, we identified nine
independent predictive factors that were correlated
with the not-cured outcome in the middle-aged co-
hort: Neu% , BUN, time to clinical stability >9 days
(positive factor), loss of appetite, anemia, confusion,
being retired or unemployed, Gram-negative bacterial
infection (positive factor) and educational level less
than high school (Table 6-1, 6-2, 6-3).
DISCUSSION
The principal findings of this study were as follows. 1)
Integrated medical intervention resulted in a not-cured
outcome in 73.8% and 74.7% of middle-aged and el-
derly patients, respectively. 2) The risk factors for not
cured differed significantly between middle-aged and
elderly patients. 3) Independent risk factors correlated
with not cured in elderly patients were greater respira-
tion rate, CRP, cost of hospitalization and PSI, plus
anemia, gasping, confusion and moist rales. 4) Inde-
pendent risk factors correlated with not cured in mid-
dle-aged patients were increased Neu% and BUN, plus
loss of appetite, anemia, confusion, being retired or un-
employed, and educational level less than high school;
protective factors were Gram-negative bacterial infec-
tion and time to clinical stability >9 days. It should be
noted that the incidence of not cured in this study was
higher than that reported previously[26,31] principally
due to our definition of outcome, which encompassed
treatment failure, improvement followed by relapse,
and abnormal radiological or laboratory findings. This
definition is stricter than outcomes that are defined on-
ly by symptoms or signs, such as non-responding pneu-
monia [1], or treatment failure[25] or inefficacy[32].
The predictive variables for the two cohorts differed ex-
cept for anemia and confusion. This may be because
people of different ages differ physiologically and psy-
chologically. Although several factors have been report-
ed in previous studies[4-23,28,33]– including anemia, con-
fusion, respiration rate, BUN, PSI, CRP, cost of hospi-
talization, education, time to clinical stability and
Gram-negative bacterial infection – some of the fac-
tors in our study require further discussion.
Although the effect of abnormal respiration rate on
CAP has generally been consistent in previous studies,
the critical value varies, having been reported to be 30/
min[4,19], 25/min[18], 24/min[6], 20/min[5] or unclear[20]. In
the present study, an effect of respiration rate on prog-
nosis appeared in the elderly cohort, and was a signifi-
cant factor in the multivariate analysis, but the collect-
ed values were analyzed as consecutive quantitative da-
ta. Therefore, we were unable to identify a critical val-
ue. There was a similar problem with BUN, the report-
ed critical value of which varies from 7 mmol/L[6], 25
mg/DL[8] and 30 mg/DL (11 mmol/L) [19-28] to 60 mg/
DL[7], with no consensus. In the present study, an effect
of BUN on prognosis appeared in the middle-aged co-
hort when the collected values were analyzed as stan-
dardized dichotomous data (group B). The original da-
ta from each center were 5.81 mmol/L, 4.71 mmol/L,
5.62 mmol/L and 4.97 mmol/L from Changchun,
Zhengzhou, Nanjing and Jinan, respectively. At first
glance, these are all in the normal range, so we cannot
identify a critical value. However, we recommend that
BUN should be considered a risk factor for not cured
if it is higher than the median value for the patient's
center.
Both increased[12-18] and decreased[21] CRP has been relat-
ed to adverse outcome in CAP. Growing evidence [9-11]
indicates that it is not a risk factor, though debate con-
tinues[34]. In this study, an effect of CRP on outcome
appeared in the elderly cohort in group B. The primary
data were 2.235 mg/L, 2.754 mg/L, 40.770 mg/L and
37.560 mg/L for Changchun, Zhengzhou, Nanjing
and Jinan, respectively. We recommend that CRP
should be considered a risk factor for not cured if its
concentration is more than four times that of the medi-
an for the patient's center.
Two factors that protected against a not-cured out-
come were identified in the middle-aged cohort: time
to clinical stability >9 days and Gram-negative bacteri-
al infection. The former was consistent with previous
studies[22], but the latter was not[15-16]. It is possible that
clinicians now pay greater attention to Gram-negative
bacterial infection, intervening when infection is found
and administering preventive therapy if necessary.
Some factors identified in this study, such as Neu% ,
moist rales, loss of appetite, gasping[5-8], educational lev-
el[14,23] and being retired or unemployed[23], have been
rarely reported in previous studies. High Neu% might
indicate that the infection is severe, because the elderly
have a lower response to the damage caused. For this
reason, we suggest considering Neu% as a risk factor
for not cured if it is higher than the median or mean
value for the patient's center. Moist rales may be a risk
factor because secretions are difficult to discharge due
to the pathological changes of pneumonia. Loss of ap-
petite indicates poor function of the digestive or ner-
vous system, and poor nutrition. Gasping always indi-
cates that the patient has a primary disease, and leads
to disorders the body's microenvironment due to hy-
perventilation. Patients with a low educational back-
ground have less knowledge of health self-care that
184
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might aid their recovery. Retired and unemployed per-
sons often worry about their health as a reaction to oth-
er burdens in their life, and these negative emotions
may affect their outcome, though the mechanism re-
mains unclear.
Although age[3,5-6, 9, 14, 16-17, 19, 22] and chest radiographic ab-
normalities [5-6, 8, 10, 13-17, 19, 22, 35] have been identified as risk
factors for CAP in many studies, some researchers be-
lieve that there is insufficient evidence to support these
two factors being valuable prognostic factors[18,35]. In
the present study, age was not found to be a prognostic
factor. However, based on our clinical experience, we
suggest that age should be considered carefully before
it is excluded from the list of risk factors, because the
age groups in the study were probably too narrow, with
293 patients in the elderly cohort and 107 in the mid-
dle-aged cohort. As for radiographic abnormalities, we
did obtain sufficient data to support these being a risk
factor.
In this study, no variable related to TCM was identi-
fied as a predictive factor, which may be because of a
lack of such variables among in the initial observations.
However, the predictive factors that were identified re-
flect the constitution (anemia, PSI), cause of disease
(being retired or unemployed, educational level) and
disease location (respiratory rate, gasping, moist rales,
Gram-negative bacterial infection, loss of appetite, con-
fusion) in TCM theory
The incidence of the outcome "not cured" in mid-
dle-aged and elderly CAP patients following combined
treatment with TCM and modern medicine was very
high. The risk factors for not cured differed with age.
Independent predictive risk factors correlated with no
cure in the elderly were: increased respiration rate,
CRP ≥four times the mean or median of that for the
patient's centre, cost of hospitalization >11, 323 RMB
and PSI>II, plus anemia, gasping, confusion and moist
rales. In middle-aged patients, independent predictive
risk factors were Neu% or BUN greater than or equal
to the mean or median for the patient's center, plus
loss of appetite, anemia, confusion, being retired or un-
employed, and educational level less than high school.
Positive factors were Gram-negative bacterial infection
and time to clinical stability >9 days. To improve ad-
verse outcomes in CAP, we must pay attention to these
risk factors.
REFERENCES
1 Mandell LA, Wunderink RG, Anzueto A, Bartlett JG,
Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher
DM, Niederman MS, Torres A, Whitney CG. Infectious
Diseases Society of America; American Thoracic Society.
Infectious disease society of America/American Thoracic
Society consensus guideline on the management of com-
munity-acquired pneumonia in adults. CID 2007; 44:
S27-63
2 British Thoracic Society Standards of Care Committe.
BTS guidelines for the management of community ac-
quired pneumonia in adults. Thorax 2001; 56: 1-64
3 Kothe H, Bauer T, Marre R, Suttorp N, Welte T, Dalhoff
K. Competence Network for Community-Acquired Pneu-
monia study group. Outcome of community-acquired
pneumonia: influence of age, residence status and antimi-
crobial treatment. Eur Respir J 2008; 32: 139-146
4 Cabré M, Serra-Prat M, Bolíbar I, Pallarés R, Grupo Co-
laborador de Neumonia Adquirida en la Comunidad.
Prognostic factors of community acquired pneumonia in
very old patients. Med Clin (Barc) 2006; 127: 201-205
(Spanish)
5 Saldías F, Farías G, Villarroel L, Valdivia G, Mardónez
JM, Díaz A. Development of an instrument to assess the
severity of community acquired pneumonia among hospi-
talized patients. Rev Med Chil 2004; 132: 1037-1046
(Spanish)
6 WS Lim, S Lewis, JT Macfarlane. Severity prediction
rules in community-acquired pneumonia: a validation
study. Thorax 2000; 55: 219-223
7 Benito JR, Montejo JM, Cancelo L, Zalacaín R, López L,
Fernández Gil de Pareja J, Alonso E, O?ate J. Communi-
ty-acquired pneumonia due to Legionella pneumophila se-
rogroup 1. Study of 97 cases. Enferm Infecc Microbiol
Clin 2003; 21: 394-400 (Spanish)
8 Gil DR, Undurraga PA, Saldías PF, Jiménez PP, Barros
MM. Prognostic factors and outcome of community-ac-
quired pneumonia in hospitalized adult patients. Rev Med
Chil 2006; 134: 1357-1366 (Spanish)
9 Tejera A, Santolaria F, Diez ML, Alemán-Valls MR,
González-Reimers E, Martínez-Riera A, Milena-Abril A.
Prognosis of community acquired pneumonia (CAP): val-
ue of triggering receptor expressed on myeloid cells-1
(TREM-1) and other mediators of the inflammatory re-
sponse. Cytokine 2007; 38: 117-123
10 Boussekey N, Leroy O, Alfandari S, Devos P, Georges H,
Guery B. Procalcitonin kinetics in the prognosis of severe
community-acquired pneumonia. Intensive Care Med
2006; 32: 469-472
11 Haeuptle J, Zaborsky R, Fiumefreddo R, Trampuz A, Stef-
fen I, Frei R, Christ-Crain M, Müller B, Schuetz P. Prog-
nostic value of procalcitonin in Legionella pneumonia.
Eur J Clin Microbiol Infect Dis 2009; 28: 55-60
12 Menéndez R, Martínez R, Reyes S, Mensa J, Filella X,
Marcos MA, Martínez A, Esquinas C, Ramirez P, Torres A.
Biomarkers improve mortality prediction by prognostic
scales in community-acquired pneumonia. Thorax 2009;
64: Epub ahead of print
13 Lisboa T, Blot S, Waterer GW, Canalis E, de Mendoza D,
Rodriguez A, Rello J. Community-Acquired Pneumonia
Intensive Care Units Study Investigators. Radiological pro-
gression of Pulmonary Infiltrates predicts a worse progno-
sis in Severe Community-Acquired Pneumonia than Bacte-
remia. Chest 2009; 135: 165-172
14 Mortensen EM, Kapoor WN, Chang CC, Fine MJ. As-
sessment of mortality after long-term follow-up of patients
with community-acquired pneumonia. Clin Infect Dis
2003; 37: 1617-1624
15 Garcia-Vidal C, Carratala J. Early and late treatment fail-
185
JTCM |www. journaltcm. com June 15, 2012 |volume 32 | Issue 2 |
Li JS et al. Prognosis factors of CAP in patients aged ≥ 45 yrs
ure in community-acquired pneumonia. Semin Respir
Crit Care Med 2009; 30: 154-160
16 Roson B, Carratala J, Fernandez Sabe N, Tubau F, Manre-
sa F, Gudiol F. Causes and factors associated with early fail-
ure in hospitalized patients with community-acquired
pneumonia. Arch Intern Med 2004; 164: 502-508
17 Aliberti S, Amir A, Peyrani P, Mirsaeidi M, Allen M, Mof-
fett BK, Myers J, Shaib F, Cirino M, Bordon J, Blasi F,
Ramirez JA. Ramirez. Incidence, etiology, timing, and risk
factors for clinical failure in hospitalized patients with
community-acquired pneumonia. Chest 2008; 134:
955-962
18 Bruns AH, Oosterheert JJ, Prokop M, Lammers JW, Hak
E, Hoepelman AI. Patterns of resolution of chest radio-
graph abnormalities in adults hospitalized with severe com-
munity-acquired pneumonia. Clin Infect Dis 2007; 45:
983-991
19 España PP, Capelastegui A, Gorordo I, Esteban C, Oribe
M, Ortega M, Bilbao A, Quintana JM. Development and
validation of a clinical prediction rule for severe communi-
ty-acquired pneumonia. Am J Respir Crit Care Med 2006;
174: 1249-1256
20 Martínez-Moragón E, García Ferrer L, Serra Sanchis B,
Fernández Fabrellas E, Gómez Belda A, Julve Pardo R.
Community-acquired pneumonia among the elderly: dif-
ferences between patients living at home and in nursing
homes. Arch Bronconeumol 2004; 40: 547-552
21 Endeman H, Schelfhout V, Voorn GP, van Velzen-Blad
H, Grutters JC, Biesma DH. Clinical features predicting
failure of pathogen identification in patients with commu-
nity acquired pneumonia. Scand J Infect Dis 2008; 40:
715-720
22 Garcia-Vidal C, Carratalà J, Díaz V, Dorca J, Verdaguer
R, Manresa F, Gudiol F. Factors associated with prolonged
hospital stay in community-acquired pneumonia. Enferm
Infecc Microbiol Clin 2009; 27: 160-164
23 Jasti H, Mortensen EM, Obrosky DS, Kapoor WN, Fine
MJ. Causes and risk factors for rehospitalization of pa-
tients hospitalized with community-acquired pneumonia.
Clin Infect Dis 2008; 46: 550-556
24 Li JS, Cheng L. Thinking on Current Research Situation
of Pneumonia in the Elderly Treaded by Traditional Chi-
nese Medicine. Chinese Journal of Integrated Traditional
and Western Medicine in Intensive and Critical Care
2000; 7: 326-328 (Chinese)
25 Zhao DH, Li YJ, Xie SM, Zhao M, Yang JB. Consider-
ation for clinical efficacy evaluation criterion in guidance
for clinical trials of antibacterial agents in China. Chin J
Clin Pharmacol 2008; 24: 564-565
26 Nelson Iucif Jr, Juan S Yazlle Rocha. Study of inequalities
in hospital mortality using the Charlson comorbidity in-
dex. Rev Saúde Pública 2004; 38: 1-6
27 Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld
LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A
Prediction rule to identify low-risk patients with communi-
ty-acquired pneumonia. N Engl J Med 1997; 336:
243-250
28 Chinese Society of Respiratory Diseases. Diagnosis and
treatment guideline of community-acquired pneumonia.
Chin J Tuberc Respir Dis 2006; 2: 651-655 (Chinese)
29 ICH E9: Statistical Principles For Clinical Trials. 1998
30 Ding H, Zhao Y, Yu H, Su BH, Chen F. Quantitative
analysis of laboratory data in multi center clinical trials.
Chin J Clin Pharmacol Ther 2004; 9: 1193-1196
31 FDA. Guidance for industry: evaluating clinical studies of
antimicrobials in the division of anti-infective drugs prod-
ucts. 1997
32 Ministry of Health of the People's Republic of China.
Guidelines for Antimicrobial Agents in Clinical Trials.
1988
33 Kamath AV, MYint PK, Vowler SL, Harrison BD. Is it
time to rethink the urea criterion in CURB-65. Eur Respir
J 2006; 27: 1321-1322
34 Boussekey N, Van Grunderbeeck N, Leroy O. CRP: a
new prognosis marker in community-acquired pneumo-
nia. Am J Med 2008; 121: e21
35 Lim WS, Macfarlane JT. Defining prognostic factors in
the elderly with community acquired pneumonia: a case
controlled study of patients aged > or = 75 yrs. Eur Respir
J 2001; 17: 200-205
186
